- Home
- SCYX vs AXIL Comparison
SCYX vs AXIL Comparison
Compare SCYX & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCYX | AXIL |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.4M | 39.5M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SCYX | AXIL |
|---|---|---|
| Price | $5.05 | $6.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $36.33 | N/A |
| AVG Volume (30 Days) | ★ 259.2K | 12.1K |
| Earning Date | 11-04-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.36 | ★ 230.00 |
| EPS | N/A | ★ 0.33 |
| Revenue | $257,000.00 | ★ $30,847,570.00 |
| Revenue This Year | N/A | $26.77 |
| Revenue Next Year | $906.41 | $17.73 |
| P/E Ratio | ★ N/A | $18.76 |
| Revenue Growth | N/A | ★ 17.48 |
| 52 Week Low | $0.57 | $4.28 |
| 52 Week High | $6.09 | $9.86 |
Technical Indicators
Market Signals| Indicator | SCYX | AXIL |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 49.68 |
| Support Level | $4.65 | $6.02 |
| Resistance Level | $5.44 | $6.19 |
| Average True Range (ATR) | 0.43 | 0.24 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 68.31 | 68.57 |
Price Performance
Historical ComparisonAbout SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.